MIRA
INFORM REPORT
|
Report Date : |
24.10.2007 |
IDENTIFICATION DETAILS
|
Name : |
J.S. ENTERPRISES CO. |
|
|
|
|
Registered Office : |
# 305 Daenong Bldg., 33-1, Mapo-Dong, Mapo-Gu, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
06/2004 |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Pharmaceutical Products & Food Products |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Basic
|
Company
Name |
J.S. ENTERPRISES CO. |
|
Registered Address |
33-1, Mapo-Dong, Mapo-Gu, |
|
Building |
#305 Daenong Bldg., |
|
Zip Code |
121-708 |
|
Tel |
+82-2-714-5500 |
|
Fax |
+82-2-717-0964~5 |
|
E-mail |
admin@jsecorp.com;overseas@jsecorp.com |
|
Website |
|
|
Trading Address |
#305 Daenong Bldg., 33-1, Mapo-Dong,
Mapo-Gu, |
|
Tel |
+82-2-717-0471~2 |
|
Fax |
+82-2-717-0964~5 |
|
Type |
Import/Export |
|
Industry |
Pharmaceutical Products & Food Products |
|
Established (mm/dd/yyyy) |
06/2004 |
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Pharmaceuticals |
|
Sell |
Health Care Products |
|
Sell |
Cosmetic products |
|
Sell |
Fine chemicals |
CEO’s
|
Name |
N/A |
|
Address |
N/A |
|
Date of Birth |
N/A |
|
Title |
Owner |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital |
Not Applicable to
the Sole Proprietorship |
|
Employees |
N/A |
|
Formation |
Sole Proprietorship |
|
Bank Details |
N/A |
|
Corporate Registered No. |
Not Applicable to the Sole Proprietorship |
|
Business Registered No. |
N/A |
|
Permit & Licenses |
N/A |
|
Shareholder Position |
The owner has 100% shares. |
|
Company History |
06/2004
Established 12/13/2005 Moved to the present address
from Rm.205-702, Hiperion, 961-1, Mok 1(il)-dong, Yangcheon-gu, |
The subject’s
information is very limited because it is a sole proprietorship company not having
any obligation to open its information. We contacted the subject for the
interview by the phone, but Mr. Kim Ho-Gon/Mager has rejected to open their
information without opening who is about to know on the company.
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Day |
|
Owner |
Mr. |
N/A |
Male |
Korean |
|
|
Manager |
Mr. |
Kim Ho-Gon |
Male |
Korean |
|
Financials
The financial is
not available.
Products,
Technologies, Services
Description
|
Main Products & Services |
Pharmaceuticals - Active pharmaceutical ingredients (APIs) - Finished products - Intermediates Health Care Products - Health foods - Nutrition supplements Cosmetic products - Natural extracts - Synthetic ingredients Fine chemicals |
Sales by Region (Activity
& Markets)
The Subject deals with the companies in
Court Action
Not Available
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)